How to Buy Cytomx Therapeutics Stock
Cytomx Therapeutics Inc
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer.
Cytomx Therapeutics stock last closed at $2.75, down 8.03% from the previous day, and has increased 88.36% in one year. It has overperformed other stocks in the Biotechnology industry by 1.65 percentage points. Cytomx Therapeutics stock is currently +587.5% from its 52-week low of $0.40, and -11.15% from its 52-week high of $3.10.
There are currently 80.62M CTMX shares outstanding. The market cap of CTMX is $221.71M. In the last 24 hours, 1.98M CTMX shares were traded.
How to Buy Cytomx Therapeutics Stock
Not sure how to invest in Cytomx Therapeutics stock? Here's how.
- Choose where to buy Cytomx Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Cytomx Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your payment method and add your information.
- Analyze Cytomx Therapeutics stock: The Cytomx Therapeutics ticker symbol is CTMX. Is Cytomx Therapeutics stock a good investment? Should you buy shares of CTMX? How do CTMX's underlying business fundamentals look? Do top analysts think Cytomx Therapeutics is a good buy? Why has CTMX's stock price moved recently? (Hint: Our stock market research website can help you figure out if CTMX is a good stock to buy).
- Make your CTMX buy order: Decide if you will purchase CTMX shares at the current market price or use a limit order to purchase CTMX stock at a particular price.
- Get notifications regarding your CTMX investment: Create a watchlist to keep tabs on your position in Cytomx Therapeutics shares.
Step 1: Choose where to buy Cytomx Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy CTMX stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you can buy CTMX today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start a new trading account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on one of the best stock trading apps, your next step is to transfer the money for your investment:
Watch the video below to see the process of depositing funds into your brokerage account.
Step 4: Analyze Cytomx Therapeutics stock
After you have selected the best place to buy Cytomx Therapeutics stock, it's very important to evaluate their stock before you invest, so you actually comprehend the risk and upside.
Cytomx Therapeutics shares quick numbers
Fundamentals of Cytomx Therapeutics
WallStreetZen was created to help average investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on CTMX's stock page.
Is CTMX stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge CTMX's true value.
Using relative valuations measures:
- CTMX could be undervalued based on its P/E ratio of 5.61x, relative to Biotechnology industry P/E ratio of -108.97x
- CTMX may be overvalued based on its P/B ratio of 8.85x, relative to Biotechnology industry P/B ratio of 4.66x
- CTMX could be undervalued based on its PEG ratio of 0.05x
You can do additional valuation analysis on CTMX's stock here.
CTMX Financial Health
Positive Health Checks:
- CTMX profit margin has gone up from 13.9% to 28.2% in the past year.
- There are more short-term assets than short-term liabilities on the CTMX balance sheet.
- There are more short-term assets than long-term liabilities on the CTMX balance sheet.
- CTMX has $80.91M in cash and short term investments. This is sufficient to cover its annual cash burn of $81.54M.
- Total CTMX debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
- CTMX has cash burn of 81543000. It does not have sufficient cash and short-term investments to cover this.
- CTMX has a relatively high debt to equity ratio of 2.93.
Is it a good time to buy CTMX stock, according to analysts?
Out of 2 sell side analysts who give forecasts on CTMX, the consensus analyst rating on Cytomx Therapeutics is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Cytomx Therapeutics stock forecast page.
CTMX Technicals
CTMX Performance Metrics
Last year, CTMX earnings were $41.60M. Over the past 1 years, CTMX's earnings have gone up by 145% per year. This was faster than the Biotechnology industry average of 8.66%.
Last year, CTMX revenue was $147.56M. Over the past 5 year, CTMX's revenue has gone up by 25.71% per year. This was slower than the Biotechnology industry average of 43.24%.
Dive into CTMX's earnings and revenue performance here.
Are CTMX insiders buying or selling the stock?
Over the last 12 months, insiders at CTMX have sold more shares than they have bought.
Marcia Belvin, SVP Chief Scientific Officer of CTMX, was the latest CTMX insider to sell. They sold $11,687.69 worth of CTMX stock on Mar 18, 2025.
Dig into more about who owns CTMX stock here.
Can I rely on CTMX as an income stream?
No, Cytomx Therapeutics doesn't provide an income stream by paying out dividends.
CTMX Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your CTMX buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you require more assistance buying stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your CTMX investment
Now that you own some shares in CTMX, you'll want to keep up with your investment.
Create a watchlist to track the latest developments regarding your CTMX stock.
CTMX Feed
How to Buy Stock in Cytomx Therapeutics
To reiterate, here are the 6 steps for buying Cytomx Therapeutics stock:
- Choose where to buy Cytomx Therapeutics stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Analyze Cytomx Therapeutics stock
- Make your CTMX buy order
- Get notifications regarding your CTMX investment
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your investment in Cytomx Therapeutics, get started below.
More Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.